Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 415

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 415
---
 | ​ | ​                                   | $ |  -323,891 | ​ | ​ | ​ | ​                                  | $ | -2,035,985 | ​ | ​ | ​ | ​                                  | $ |   -739,623 | ​ | ​ |
| Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption | ​ | ​ | ​                                   | ​ |  7,173,964 | ​ | ​ | ​ | ​                                   | ​ | 1,977,122 | ​ | ​ | ​ | ​                                  | ​ |  7,211,886 | ​ | ​ | ​ | ​                                  | ​ |  1,603,176 | ​ | ​ |
| Basic and diluted net loss per share, Class A common stock subject to possible redemption                  | ​ | ​ | ​                                   | $ |      -0.09 | ​ | ​ | ​ | ​                                   | $ |     -0.04 | ​ | ​ | ​ | ​                                  | $ |      -0.28 | ​ | ​ | ​ | ​                                  | $ |      -0.09 | ​ | ​ |
| Basic and diluted weighted average shares outstanding, Class B common stock                                | ​ | ​ | ​                                   | ​ |          — | ​ | ​ | ​ | ​                                   | ​ | 6,150,000 | ​ | ​ | ​ | ​                                  | ​ |          — | ​ | ​ | ​ | ​                                  | ​ |  6,647,253 | ​ | ​ |
| Basic and diluted net loss per share, Class B common stock                                                 | ​ | ​ | ​                                   | $ |          — | ​ | ​ | ​ | ​                                   | $ |     -0.04 | ​ | ​ | ​ | ​                                  | $ |          — | ​ | ​ | ​ | ​                                  | $ |      -0.09 | ​ | ​ |

The accompanying notes are an integral part of these unaudited condensed financial statements. F-3

TABLE OF CONTENTS IRIS ACQUISITION CORP CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
(UNAUDITED) FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024

| ​                                                                   
 ​                                                                   | ​ 
 ​ | ​ 
 ​ | Class A Common Stock 
 Shares               |   |           |   | ​ | ​ | Amount |   |